TMCO1 is associated with POAG in the Ocular Hypertension Treatment Study (OHTS)

被引：0
|
作者：
Fingert, John H. [1 ,2 ]
Wang, Kai [2 ,3 ]
Faga, Ben [4 ]
Ortega, Lizette [3 ]
Gordon, Mae O. [5 ]
Kass, Michael A. [5 ]
Scheetz, Todd [1 ,2 ]
机构：
[1] Univ Iowa, Carver Coll Med, Ophthalmol, Iowa City, IA USA
[2] Univ Iowa, Stephen A Wynn Inst Vis Res, Iowa City, IA USA
[3] Univ Iowa, Coll Publ Hlth, Biostat, Iowa City, IA USA
[4] Univ Iowa, Coll Engn, Iowa City, IA 52242 USA
[5] Washington Univ, Sch Med, Ophthalmol, St Louis, MO USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
539; genetics; 464 clinical (human) or epidemiologic studies: risk factor assessment; 629 optic nerve;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2145
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pre- and Post-POAG Rate of Visual Field Progression in the Ocular Hypertension Treatment (OHTS) Study
    Gordon, Mae E.
    Brandt, James David
    Heuer, Dale K.
    Higginbotham, Eve J.
    Parrish, Richard K., II
    Johnson, Chris A.
    Keltner, John L.
    Huecker, Julia
    Kass, Michael A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [2] Results of the "Ocular hypertension treatment study" [Ergebnisse der "Ocular hypertension treatment study" (OHTS)]
    Pfeiffer N.
    Der Ophthalmologe, 2005, 102 (3): : 230 - 234
  • [3] Infographic of the Ocular Hypertension Study (OHTS)
    Ali Ahmad, Syed Mustafa
    Han, Ji Eun
    Mathew, Rashmi
    Henein, Christin
    EYE, 2021, 35 (08) : 2075 - 2075
  • [4] Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS)
    Brandt, JD
    Beiser, JA
    Kass, MA
    Gordon, MO
    OPHTHALMOLOGY, 2001, 108 (10) : 1779 - 1788
  • [5] Central Corneal Thickness in the Ocular Hypertension Treatment Study (OHTS)
    Brandt, James D.
    Beiser, Jlia A.
    Kass, Michael A.
    Gordon, Mae O.
    OPHTHALMOLOGY, 2020, 127 (04) : S72 - S81
  • [6] Visual field quality control in the Ocular Hypertension Treatment Study (OHTS)
    Keltner, John L.
    Johnson, Chris A.
    Cello, Kimberly E.
    Bandermann, Shannan E.
    Fan, Juanjuan
    Levine, Richard A.
    Kass, Michael A.
    Gordon, Mae O.
    JOURNAL OF GLAUCOMA, 2007, 16 (08) : 665 - 669
  • [7] Is there a penalty for delayed treatment in ocular hypertensives? Evidence from the ocular hypertension treatment study (OHTS)
    Heuer, DK
    Higginbotham, EJ
    Kass, MA
    Parrish, RK
    Gordon, MO
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U17 - U17
  • [8] Visual field technician performance in the ocular hypertension treatment study (OHTS).
    Keltner, JL
    Johnson, CA
    Cello, KE
    Kass, MA
    Gordon, MO
    Bandermann, SE
    Edwards, MA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S152 - S152
  • [9] Classification of visual field abnormalities in the ocular hypertension treatment study (OHTS)
    Keltner, JL
    Johnson, CA
    Spurr, JO
    Kass, MA
    Gordon, MO
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S69 - S69
  • [10] Correction: Infographic of the Ocular Hypertension Study (OHTS)
    Syed Mustafa Ali Ahmad
    Ji Eun Han
    Rashmi G. Mathew
    Christin Henein
    Eye, 2021, 35 (8) : 2337 - 2337
12345